Home Clinical Topics FDA approves new drug for severe drooling

FDA approves new drug for severe drooling

On July 28, the U.S. Food and Drug Administration (FDA) approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years. Read more at here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here